MIR4309

Across TCGA pan-cancer cohorts, MIR4309 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR4309 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4309 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4309 expression acts as an unfavorable survival marker.

KIRC, SKCM, and LUAD are the cancer types where MIR4309 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.757	0.882	.010	60	view →
SKCM	OS	Tertile	All	0.249	0.781	.011	54	view →
LUAD	OS	Tertile	III,IV	0.053	0.661	<.001	36	view →
ACC	OS	Tertile	All	0.268	0.802	.010	36	view →
SARC	OS	Tertile	All	0.020	0.839	<.001	36	view →
LIHC	OS	Tertile	All	0.255	0.773	.012	27	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
LGG	OS	Tertile	All	0.552	0.889	<.001	15	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR4309–KIRC (OS)

Open the KIRC breakdown →